Menveo

Menveo

vaccine, meningococcal

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Per dose: Powd for inj Meningococcal group A oligosaccharide 10 mcg, soln for inj Meningococcal group C oligosaccharide 5 mcg, meningococcal group W135 oligosaccharide 5 mcg, meningococcal group Y oligosaccharide 5 mcg
Indications/Uses
Active immunization of adults & childn from 2 yr at risk of exposure to Neisseria meningitidis groups A, C, W135 & Y to prevent invasive disease.
Dosage/Direction for Use
Adult & childn >5 yr 0.5 mL single IM inj, 2-5 yr 0.5 mL single IM inj. 2nd dose may be administered 2 mth after 1st dose.
Contraindications
Hypersensitivity to vaccine, diphtheria toxoid (CRM197) or life-threatening reaction after previous inj. Postpone vaccination in patients suffering from acute severe febrile illness.
Special Precautions
Hypersensitivity. Not to be administered SC, intravascularly or intradermally. Not for protection against infections caused by any other serogroups of N meningitidis not present in vaccine. Individuals w/ familial complement deficiencies, functional or anatomical asplenia. Syncope; thrombocytopenia, bleeding disorders. Immunocompromised patients. Avoid injury from fainting. Concomitant use w/ anticoagulant therapy. May affect ability to drive & use machines. Pregnancy. Childn <2 yr. Elderly >65 yr.
Adverse Reactions
Headache; nausea; myalgia; inj site pain, erythema (≤50 mm) & induration (≤50 mm), malaise. Rash; arthralgia; inj site erythema (>50 mm) & induration (>50 mm), fever ≥38°C, chills. Childn 2-10 yr: Eating disorders; sleepiness; irritability. Vomiting, diarrhea.
Drug Interactions
Diminished immunological response w/ immunosuppressants.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AH08 - meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated ; Belongs to the class of meningococcal bacterial vaccines.
Presentation/Packing
Form
Menveo inj
Packing/Price
((powd & soln vial) 1 dose) 0.5 mL x 1 × 2's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in